Definition of subtypes of essential thrombocythaemia and relation to polycythaemia vera based on JAK2 V617F mutation status: a prospective study.

Definition of subtypes of essential thrombocythaemia and relation to polycythaemia vera based on JAK2 V617F mutation status: a prospective study.

BACKGROUND: An acquired V617F mutation in JAK2 occurs in most patients with polycythaemia vera, but is seen in only half those with essential thrombocythaemia and idiopathic myelofibrosis. We aimed to assess whether patients with the mutation are biologically distinct from those without, and why th...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:	Campbell, P, Scott, L, Buck, G, Wheatley, K, East, C, Marsden, J, Duffy, A, Boyd, E, Bench, A, Scott, M, Vassiliou, G, Milligan, D, Smith, SR, Erber, W, Bareford, D, Wilkins, B, Reilly, J, Harrison, C, Green, A
Formáid:	Journal article
Teanga:	English
Foilsithe / Cruthaithe:	2005

Míreanna comhchosúla

JAK2 V617F mutation identifies a biologically distinct subtype of essential thrombocythemia which resembles polycythemia vera.
de réir: Green, A, et al.
Foilsithe / Cruthaithe: (2005)

Skin cancer in essential thrombocythaemia and polycythaemia vera patients treated with hydroxycarbamide
de réir: Abhinav Mathur, et al.
Foilsithe / Cruthaithe: (2022-11-01)

Cerebral venous sinus thrombosis in JAK2 V617F positive polycythaemia vera presenting as a haemorrhagic stroke
de réir: N. T. Weerasinghe, et al.
Foilsithe / Cruthaithe: (2021-12-01)

Real world experience with ropeginterferon alpha-2b (Besremi) in essential thrombocythaemia and polycythaemia vera following exposure to pegylated interferon alfa-2a (Pegasys)
de réir: Jumoke Okikiolu, et al.
Foilsithe / Cruthaithe: (2023-01-01)

Polycythaemia vera and central sleep apnoea.
de réir: Stradling, JR, et al.
Foilsithe / Cruthaithe: (1980)

Recurrent Episodes of Angioedema as Presenting Feature of JAK2-Positive Myeloproliferative Disorder Consistent with Polycythaemia Vera
de réir: Laith Al-Azrai, et al.
Foilsithe / Cruthaithe: (2021-07-01)

Profile of polycythaemia vera in South Western Nigeria
de réir: Patrick Olanrewaju Osho, et al.
Foilsithe / Cruthaithe: (2022-01-01)

Evaluation of erythrocytapheresis compared to phlebotomy in polycythaemia vera patients
de réir: Sergio Cabibbo, et al.
Foilsithe / Cruthaithe: (2024-10-01)

Improvement in polycythaemia vera after parathyroidectomy for primary hyperparathyroidism
de réir: Pavai Sthaneshwar, et al.
Foilsithe / Cruthaithe: (2023-10-01)

Splenic Infarctions in Polycythaemia Vera are Not Always a Catastrophe
de réir: ELMustafa Abdalla, et al.
Foilsithe / Cruthaithe: (2022-06-01)

The janus kinase 2 (JAK2) mutation: A review of its role in polycythaemia vera and other myeloproliferative disorders
de réir: M U Nwagu
Foilsithe / Cruthaithe: (2011-01-01)

A guideline for the management of specific situations in polycythaemia vera and secondary erythrocytosis
de réir: McMullin, M, et al.
Foilsithe / Cruthaithe: (2018)

Study of JAK2V617F gene allele burden in polycythemia vera
de réir: F. Khalilova, et al.
Foilsithe / Cruthaithe: (2020-10-01)

Longitudinal trends of peripheral blood counts in polycythaemia vera and essential thrombocythemia patients in the UK
de réir: Lewis Carpenter, et al.
Foilsithe / Cruthaithe: (2022-08-01)

Advances in management of primary myelofibrosis and polycythaemia vera: Implications in clinical practice
de réir: Shanti Amé, et al.
Foilsithe / Cruthaithe: (2023-08-01)

MTAP-related increased erythroblast proliferation as a mechanism of polycythaemia vera
de réir: Chartsiam Tipgomut, et al.
Foilsithe / Cruthaithe: (2021-11-01)

A guideline for the diagnosis and management of polycythaemia vera. A British Society for haematology guideline
de réir: McMullin, M, et al.
Foilsithe / Cruthaithe: (2018)

A man with concomitant polycythaemia vera and chronic myeloid leukemia: the dynamics of the two disorders
de réir: Bee, P.C., et al.
Foilsithe / Cruthaithe: (2010)

Sigmoid Venous Thrombosis in JAK2 V617F Mutated Polycythemia Vera
de réir: Cilomar Martins De Oliveira Filho, et al.
Foilsithe / Cruthaithe: (2022-01-01)

Detection of JAK2 exon 12 mutations in 15 patients with JAK2V617F negative polycythemia vera
de réir: Susanne Schnittger, et al.
Foilsithe / Cruthaithe: (2009-03-01)

MPL mutations in myeloproliferative disorders: analysis of the PT-1 cohort.
de réir: Beer, P, et al.
Foilsithe / Cruthaithe: (2008)

PB2192: JAK2 V617F ALLELE BURDEN AND THROMBOTIC EVENTS IN PATIENTS WITH JAK2 V617F POSITIVE POLYCYTHEMIA VERA OR ESSENTIAL THROMBOCYTHEMIA AT HIGH RISK OF THROMBOSIS
de réir: Yun Hui Hwang, et al.
Foilsithe / Cruthaithe: (2023-08-01)

Extent of hematopoietic involvement by TET2 mutations in JAK2V617F polycythemia vera
de réir: Sabina I. Swierczek, et al.
Foilsithe / Cruthaithe: (2011-05-01)

Cerebral venous sinus thrombosis in polycythemia vera patients with JAK2V617F mutation
de réir: Hui-Xin Shen, et al.
Foilsithe / Cruthaithe: (2021-05-01)

Polyglobulia Masquerading as Polycythaemia Vera Presenting as Superior Mesenteric Vein Thrombosis: A Case Report
de réir: Janhavi Nitin Mahajan, et al.
Foilsithe / Cruthaithe: (2022-10-01)

Development and validation of a sequential two-step algorithm for the screening of individuals with potential polycythaemia vera
de réir: Miguel Piris-Villaespesa, et al.
Foilsithe / Cruthaithe: (2021-01-01)

PB2178: EVALUATION OF JAK2 EXON 12 MUTATIONS IN PATIENTS WITH JAK2 (V617F)-NEGATIVE POLYCYTHEMIA VERA
de réir: Sahar Khosravi, et al.
Foilsithe / Cruthaithe: (2023-08-01)

Clinical significance of MPL mutations in essential thrombocythemia: Analysis of the PT-1 cohort.
de réir: Beer, P, et al.
Foilsithe / Cruthaithe: (2007)

Impact of platelet glycoprotein polymorphisms upon clinical events in essential thrombocythaemia patients enrolled in the PT1 trial
de réir: Robinson, SE, et al.
Foilsithe / Cruthaithe: (2007)

Bone marrow pathology in essential thrombocythemia: interobserver reliability and utility for identifying disease subtypes.
de réir: Wilkins, B, et al.
Foilsithe / Cruthaithe: (2008)

Distinguishing essential thrombocythemia JAK2V617F from polycythemia vera: limitations of erythrocyte values
de réir: Richard T. Silver, et al.
Foilsithe / Cruthaithe: (2019-11-01)

JAK2 p.V617F Variants in Non-Blood DNA from Patients with Polycythemia Vera
de réir: Naoki Mori, et al.
Foilsithe / Cruthaithe: (2023-08-01)

Absence of JAK2 V617F-mutated polycythemia vera in obstructive sleep apnea-associated erythrocytosis
de réir: Stephen E. Langabeer
Foilsithe / Cruthaithe: (2022-12-01)

JAK2 V617F prevalence in Brazilian patients with polycythemia vera, idiopathic myelofibrosis and essential thrombocythemia
de réir: Bárbara da Costa Reis Monte-Mór, et al.
Foilsithe / Cruthaithe: (2007-03-01)

Association of polycythemia vera with positive JAK2V617F mutation and myasthenia gravis: A report of two cases
de réir: Sreethish Sasi, et al.
Foilsithe / Cruthaithe: (2021-01-01)

Modification of British committee for standards in haematology diagnostic criteria for essential thrombocythaemia
de réir: Harrison, C, et al.
Foilsithe / Cruthaithe: (2014)

Modification of British Committee for Standards in Haematology diagnostic criteria for essential thrombocythaemia.
de réir: Harrison, C, et al.
Foilsithe / Cruthaithe: (2014)

Polycythemia vera: Correlation of JAK2V617F mutation with clinicohematologic characteristics. A single centre experience.
de réir: Deepti Mutreja, et al.
Foilsithe / Cruthaithe: (2014-08-01)

Decrease in JAK2V617F allele burden is not a prerequisite to clinical response in patients with polycythemia vera
de réir: Emil Kuriakose, et al.
Foilsithe / Cruthaithe: (2012-04-01)

Enhanced calreticulin expression in red cells of polycythemia vera patients harboring the JAK2V617F mutation
de réir: Mégane Brusson, et al.
Foilsithe / Cruthaithe: (2017-07-01)